Menald Pharmaceuticals Private Limited
About Menald Pharmaceuticals Private Limited
Data last updated:
Menald Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC310431. Its GSTIN is 07AAKCM7640R1ZN (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohammad Noman Akhtar and Aparajita Panda.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at House No. N – 84 Second Floor Thokar No. 05 Abul Fazal Enclave Part – I Jamia Nagar, Okhla, New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2022, the company reported a revenue of ₹36.98 Lakh, a decline of 63% compared to the previous year. For the same year it recorded a net loss of ₹2.4 Lakh (net margin -6.5%) and EBITDA of -₹1.83 Lakh (EBITDA margin -4.9%). Revenue has declined at a compounded annual rate (CAGR) of 42% over three years.
As per MCA filings, the company has open charges of ₹7 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Menald Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. N – 84 Second Floor Thokar No. 05 Abul Fazal Enclave Part – I Jamia Nagar, Okhla, New Delhi, Delhi, India – 110025
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Menald Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Menald Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Menald Pharmaceuticals Private Limited, buy the company report.
Financials of Menald Pharmaceuticals Private Limited
FY 2022 filings availableMenald Pharmaceuticals Private Limited reported revenue of ₹36.98 Lakh (down 63% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 42% over three years, including a 63% fall in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.83 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.4 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.9% | ||||
| Net Profit Margin | -6.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Menald Pharmaceuticals Private Limited, buy the company report.
Board of directors of Menald Pharmaceuticals Private Limited
Menald Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Noman Akhtar Also directs: Hariom Pharmaceuticals Private Limited | Director | 11 Jan 2017 | 9 Years 9 Months | Current |
| Aparajita Panda | Director | 14 May 2019 | 7 Years 5 Months | Current |
| Asma Rais | Director | 14 May 2019 | 7 Years 5 Months | Current |
Auditor
Menald Pharmaceuticals Private Limited is audited by SHARMA GUPTA & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHARMA GUPTA & ASSOCIATES | FY 2019 | 027039N |
Shareholding
The shareholding of Menald Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Menald Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Sep 2018 | 100217104 | Others | ₹7 Lakh | Open |
To see the full charge records of Menald Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Menald Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Menald Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Menald Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKCM7640R1ZN | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Menald Pharmaceuticals Private Limited, buy the company report.
Recent activity
Menald Pharmaceuticals Private Limited has 5 board changes on record since 2017: 3 appointments and 2 cessations. The latest: Varun Arya ceased to be Director on 16 May 2019.
Frequently asked questions
Menald Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 January 2017 (9+ years old) and is registered under CIN U74999DL2017PTC310431.
Menald Pharmaceuticals has 3 current directors:
- Mohammad Noman Akhtar - Director
- Aparajita Panda - Director
- Asma Rais - Director
The latest financial statements of Menald Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Menald Pharmaceuticals is 07AAKCM7640R1ZN, registered in Delhi.
The CIN (Corporate Identification Number) of Menald Pharmaceuticals is U74999DL2017PTC310431. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Menald Pharmaceuticals was incorporated on 11 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Varun Arya ceased to be Director on 16 May 2019. Aparajita Panda was appointed as Director on 14 May 2019. Asma Rais was appointed as Director on 14 May 2019. Menald Pharmaceuticals has 5 board changes on record in total.
The registered office of Menald Pharmaceuticals is at House No. N – 84 Second Floor Thokar No. 05 Abul Fazal Enclave Part – I Jamia Nagar, Okhla, New Delhi, Delhi, India – 110025.
Menald Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Menald Pharmaceuticals has open charges of ₹7 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
